HOUSE-BILL 8651: H.R.8651 - Advancing Safe Medications for Moms and Babies Act of 2026
AI-Powered Summary
HOUSE-BILL 8651 aims to enhance the inclusion of pregnant and lactating women in clinical research, addressing significant gaps in medical studies that often overlook these populations. The legislation focuses on major themes such as health care rights, informed consent, and the right to participate in research. Key provisions include the empowerment of the Secretary of Health and Human Services to update FDA regulations to ensure pregnant women are included in clinical trials, the establishment of an education campaign to inform these women about their research options, and a prioritization process for research on medications used by this demographic. Implementation will require timely regulatory updates and the launch of educational initiatives, with the potential impact being improved health outcomes for mothers and infants, as well as stronger protections for pregnant women in research settings. However, there are concerns regarding the adequacy of protections and the robustness of informed consent processes, which will need to be addressed to fully realize the bill's objectives.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill has significant positive implications for individual rights, particularly for pregnant and lactating women, by ensuring their inclusion in medical research. This inclusion is essential for developing safe medications that cater to their unique health needs, thereby promoting their health and the health of their infants.
Key Individual Rights
- Right to Health Care
- Equal Protection under the Law
- Informed Consent
Constitutional Provisions
- Fourteenth Amendment - Equal Protection Clause
- Fourteenth Amendment - Due Process Clause
Potential Constitutional Challenges Or Support
While the bill is largely supportive of constitutional principles, there may be concerns regarding the adequacy of protections for vulnerable populations. If the implementation prioritizes certain demographic groups over others, it could raise equal protection issues.
Summary
HOUSE-BILL 8651 seeks to enhance the participation of pregnant and lactating women in clinical trials, which is crucial for improving health outcomes. By addressing historical disparities in medical research, the bill aligns with constitutional principles of equal protection and the inferred right to health care, ultimately supporting the health and well-being of both mothers and infants.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 8651 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
May 4, 2026
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat